8307 — Medicskin Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$66.65m
- HK$68.18m
- HK$49.14m
- 38
- 29
- 54
- 33
Annual cashflow statement for Medicskin Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.31 | 1.31 | 4.42 | -3.03 | -3.12 |
| Depreciation | |||||
| Non-Cash Items | 1.84 | -1.02 | -0.72 | 0.789 | 0.379 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.28 | -0.959 | -9.54 | -3.84 | 3.87 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 15.3 | 9.15 | 3.89 | 3.25 | 10.5 |
| Capital Expenditures | -1.7 | -2.31 | -1.97 | -2.3 | -1.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 40.7 | 0.652 | 0.151 | -3.38 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 39 | -1.65 | -1.81 | -5.67 | -1.4 |
| Financing Cash Flow Items | 0.196 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -27.2 | -21 | -17.5 | -6.74 | -7.21 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 27 | -13.5 | -15.3 | -9.16 | 1.93 |